4.6 Article

microRNA-7: A tumor suppressor miRNA with therapeutic potential

Journal

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.biocel.2014.05.040

Keywords

microRNA-7; Tumor suppressor; Cancer; Epidermal growth factor receptor

Funding

  1. National Health and Medical Research Council (NHMRC) of Australia [634375, 458649]
  2. Cancer Council of Western Australia (CCWA)
  3. Medical Research Commercialisation Fund (MRCF)
  4. Scott Kirkbride Melanoma Research Centre (SKMRC)
  5. Royal Perth Hospital Medical Research Foundation
  6. Harry Perkins Institute of Medical Research

Ask authors/readers for more resources

microRNAs are a family of endogenous, short, non-coding RNAs that play critical roles in regulating gene expression for key cellular processes in normal and abnormal physiology. microRNA-7 is a 23 nucleotide miRNA whose expression is tightly regulated and restricted predominantly to the brain, spleen and pancreas. Reduced levels of miR-7 have been linked to the development of cancer and metastasis. As a tumor suppressor, miR-7 functions to co-ordinately downregulate a number of direct (e.g. the epidermal growth factor receptor) and indirect (e.g. phospho-Akt) growth promoting targets to decrease tumor growth in vitro and in vivo. In addition, miR-7 can increase the sensitivity of treatment-resistant cancer cells to therapeutics and inhibit metastasis. These data suggest that replacement of miR-7 ('miRNA replacement therapy') for specific human cancers could represent a new treatment approach. (C) 2014 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available